Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

iRadimed Raises FY2025 GAAP EPS Guidance from $1.60-$1.70 to $1.68-$1.72 vs $1.65 Est

Author: Benzinga Newsdesk | November 03, 2025 08:35am

iRadimed (NASDAQ:IRMD) raises FY2025 GAAP EPS guidance from $1.60-$1.70 to $1.68-$1.72 vs $1.65 analyst estimate..

Posted In: IRMD